《新股表現》MOG(01942.HK)暗盤平開1元
根據輝立交易平台顯示,明天掛牌的MOG Holdings(01942.HK)暗盤平開報1元欠承接,曾低見0.75元,現造0.81元,較上市價1元,低19%,成交102萬股。
MOG為馬來西亞第二大光學產品零售商,旗下光學產品品牌組合包括逾220個國際品牌及自有品牌,可迎合眼鏡零售市場的各種價格。是次上市共發售1.25億股,其中10%公開發售獲39倍超購,已啟動回撥機制佔比增至30%,認購一手中籤率35%;股份以招股範圍(1-1.2元)下限定價,料集資淨額約9,110萬元,主要用作於擴張MOG零售網絡、升級和翻新MOG自有零售店、推廣MOG 11個零售品牌知名度及增強MOG定制化鏡片產能等。上市獨家保薦人中泰國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.